Home > Insider Trading > Filing (0001209191-22-023458)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1828443	Ortho Clinical Diagnostics Holdings Plc	OCDX	In Vitro & In Vivo Diagnostic Substances (2835)	981151819

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1839441	A. Michael Schlesinger	C/O Ortho Clinical Diagnostics Holdings 1001 Route 202 Raritan NJ 08869	Evp, Gc And Secretary	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares, $0.00001 Par Value	Acquisiton	2022-04-04	88,043	$6.28	175,680	No	4	M	Direct
Ordinary Shares, $0.00001 Par Value	Disposition	2022-04-04	88,043	$18.77	87,637	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares, $0.00001 Par Value	Stock Option	Disposition	2022-04-04	88,043	$0.00	88,043	$6.28

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2024-10-22	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The Reporting Person undertakes to provide, upon request by the Securities Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported in this Form 4.
Represents the weighted average sales price for the price increments ranging from $18.6200 to $18.8800.
The stock option is fully vested and exercisable.